PDS Biotechnology Corp Deferred Tax Assets, Operating Loss Carryforwards, Domestic
PDS Biotechnology Corp (PDSB) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $33.12 million as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2025-03-27
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $33.12M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $28.60M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $25.06M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $22.83M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed |
|---|---|---|
| 2024-12-31 | $33.12M 10-K · filed 2025-03-27 | |
| 2023-12-31 | $28.60M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $25.06M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $22.83M 10-K · filed 2023-03-28 | |
| 2020-12-31 | $19.76M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $16.62M 10-K · filed 2021-03-18 | |
| 2018-12-31 | $5.15M 10-K · filed 2020-03-27 | $27.01M 10-K · filed 2019-02-21 |
| 2017-12-31 | $21.31M 10-K · filed 2019-02-21 | |
| 2016-12-31 | $23.64M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $14.76M 10-K · filed 2017-03-02 | $16.14M 10-K · filed 2016-03-08 |
| 2014-12-31 | $8.11M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |